Prosecution Insights
Prosecution Insights
30 pending office actions • 13 clients • 26 examiners • 17 art units • 0 of 30 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (7%) |
| §103 only | 10 (33%) |
| §102 only | 1 (3%) |
| §112 only | 3 (10%) |
| Double-patenting + other | 4 (13%) |
| Multi-statute (no §101) | 9 (30%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCOLLUM, ANDREA K | 2 | 60.8% | +32.3% |
| COFFA, SERGIO | 2 | 61.2% | +33.1% |
| LU, CHENG | 2 | 53.7% | +66.2% |
| HUYNH, PHUONG N | 2 | 65.7% | +53.6% |
| PAK, MICHAEL D | 1 | 58.6% | +30.1% |
| HYDER, G.M. ALI | 1 | 90.6% | +7.3% |
| MOLOYE, TITILAYO | 1 | 63.2% | +47.0% |
| RAHMAN, MASUDUR | 1 | 71.3% | +32.3% |
| TSUI, YUNG-SHENG M | 1 | 66.4% | +7.1% |
| WANG, RUIXUE | 1 | 57.4% | +22.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18633283 | N-Terminal Capping Modules of Ankyrin Repeat Domains | COFFA, SERGIO | 86d overdue |
| 17777385 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | MCCOLLUM, ANDREA K | 30d overdue |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | O'NEILL, MARISOL ANN | 9d |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | PYLA, EVELYN Y | 28d |
| 17923070 | Hypoimmunogenic Cells and Uses Thereof in Immune Responses | HUYNH, PHUONG N | 34d |
| 18856927 | SINGLE-SHOT MULTI-B-VALUE AND TIME-DEPENDENT DIFFUSION-WEIGHTED MRI USING SPIN ECHO AND STIMULATED ECHOES WITH VARIABLE FLIP ANGLES | HYDER, G.M. ALI | — |
| 18723927 | NONHUMAN STEM CELLS AND THEIR USE FOR PRODUCTION OF CULTURED MEAT | MOLOYE, TITILAYO | — |
| 18718620 | ADENOVIRAL VECTORS | RAHMAN, MASUDUR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18633283 | N-Terminal Capping Modules of Ankyrin Repeat Domains | COFFA, SERGIO | 86d overdue |
| 17777385 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | MCCOLLUM, ANDREA K | 30d overdue |
| 17778138 | PENTAPEPTIDE AND METHODS OF USE THEREOF | COFFA, SERGIO | 28d |
| 17923070 | Hypoimmunogenic Cells and Uses Thereof in Immune Responses | HUYNH, PHUONG N | 34d |
| 19363767 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | MCCOLLUM, ANDREA K | — |
| 19363223 | ELUATE COLLECTION DURING ANTIBODY CHROMATOGRAPHY | PAK, MICHAEL D | — |
| 18723927 | NONHUMAN STEM CELLS AND THEIR USE FOR PRODUCTION OF CULTURED MEAT | MOLOYE, TITILAYO | — |
| 18718620 | ADENOVIRAL VECTORS | RAHMAN, MASUDUR | — |
| Client (Assignee) | Pending OAs |
|---|---|
| St. Jude Children's Research Hospital Inc. | 7 |
| Novartis | 5 |
| University of Illinois | 5 |
| Athebio AG | 2 |
| University of Hawaii | 2 |
| RXCELL INC. | 2 |
| Atelier Meats Corp. | 1 |
| University of Zurich | 1 |
| THOMAS JEFFERSON UNIVERSITY | 1 |
| PEAK DESIGN | 1 |
| ProVEDA Corporation | 1 |
| WASHINGTON UNIVERSITY | 1 |
| WELLNAS.CO., LTD | 1 |
| Art Unit | Apps |
|---|---|
| 1674 | 3 |
| 1658 | 3 |
| 1633 | 3 |
| 1628 | 1 |
| 3632 | 1 |
| 1615 | 1 |
| 1636 | 1 |
| 1614 | 1 |
| 1642 | 1 |
| 1647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19363767 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | Morphosys GmbH | MCCOLLUM, ANDREA K | 1674 | §102§112DP | Final Rejection | — | Pending | Oct 21, 2025 |
| 19363223 | ELUATE COLLECTION DURING ANTIBODY CHROMATOGRAPHY | Morphosys GmbH | PAK, MICHAEL D | 1674 | §112DP | Final Rejection | — | Pending | Oct 20, 2025 |
| 18856927 | SINGLE-SHOT MULTI-B-VALUE AND TIME-DEPENDENT DIFFUSION-WEIGHTED MRI USING SPIN ECHO AND STIMULATED ECHOES WITH VARIABLE FLIP ANGLES | The Board Of Trustees Of The University Of Illinois | HYDER, G.M. ALI | §101§102 | Non-Final OA | — | Pending | Oct 15, 2024 | |
| 18723927 | NONHUMAN STEM CELLS AND THEIR USE FOR PRODUCTION OF CULTURED MEAT | Atelier Meats Corp. | MOLOYE, TITILAYO | §103§112 | Non-Final OA | — | Pending | Jun 25, 2024 | |
| 18718620 | ADENOVIRAL VECTORS | UNIVERSITAET ZUERICH | RAHMAN, MASUDUR | §102§103 | Non-Final OA | — | Pending | Jun 11, 2024 | |
| 18633283 | N-Terminal Capping Modules of Ankyrin Repeat Domains | Athebio AG | COFFA, SERGIO | 1658 | §102§103§112 | Non-Final OA | 86d overdue | Pending | Apr 11, 2024 |
| 18442492 | Variants of Ankyrin Repeat Domains | Athebio AG | TSUI, YUNG-SHENG M | §112DP | Non-Final OA | — | Pending | Feb 15, 2024 | |
| 18681966 | METHODS TO DETERMINE CD4+ MEMORY T CELL RESPONSES TO SARS-COV-2 INFECTION OR VACCINATION | St. Jude Children's Research Hospital | WANG, RUIXUE | §102§103§112 | Non-Final OA | — | Pending | Feb 07, 2024 | |
| 18427042 | METHOD OF USING PACAP AND VIP PEPTIDES FOR DETECTING SHED OR CIRCULATING TUMOR CELLS IN BIOLOGICAL FLUIDS | Thomas Jefferson University | LU, CHENG | §101§112DP | Non-Final OA | — | Pending | Jan 30, 2024 | |
| 18291283 | COMBINATIONS OF ANTIGEN BINDING MOLECULES | Morphosys GmbH | HUYNH, PHUONG N | §112Other | Non-Final OA | — | Pending | Jan 23, 2024 | |
| 18541691 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF HEARING LOSS | St. Jude Children's Research Hospital | VALENROD, YEVGENY | 1628 | §112Other | Non-Final OA | 11d overdue | Pending | Dec 15, 2023 |
| 18532345 | CLOSE-PACK, HIGH-ASPECT-RATIO CAMERA TRIPOD | Peak Design | GARFT, CHRISTOPHER | 3632 | §103 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18513938 | BIOINSECTICIDAL COMPOSITIONS CONTAINING MONOTERPENES AND METHODS OF USE THEREOF | UNIVERSITY OF HAWAII | TCHERKASSKAYA, OLGA V | 1615 | §102§103§112 | Final Rejection | — | Pending | Nov 20, 2023 |
| 18464374 | CRISPR/CAS SYSTEM AND METHOD FOR GENOME EDITING AND MODULATING TRANSCRIPTION | The Board Of Trustees Of The University Of Illinois | WHITEMAN, BRIAN A | 1636 | §103 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18307253 | TOPICAL FORMULATIONS | Proveda Corporation | KETCHAM, KAREN A | 1614 | §103 | Non-Final OA | 139d overdue | Pending | Apr 26, 2023 |
| 18246052 | NOVEL HUMAN ANTIBODIES BINDING TO HUMAN CD3 EPSILON | Morphosys GmbH | LU, CHENG | 1642 | §112 | Final Rejection | — | Pending | Mar 21, 2023 |
| 18245257 | METHODS FOR TREATING OR MODULATING AN INFLAMMATORY RESPONSE | St. Jude Children's Research Hospital | LANDSMAN, ROBERT S | 1647 | §103 | Final Rejection | 24d overdue | Pending | Mar 14, 2023 |
| 18043095 | ALGINATE-COATED MESENCHYMAL STROMAL AND PROGENITOR CELLS AND METHODS FOR USING THE SAME | The Board Of Trustees Of The University Of Illinois | CONNORS, ALEXANDRA F | 1634 | §103 | Final Rejection | — | Pending | Feb 27, 2023 |
| 18041873 | Use of Amylase or Maltose to Treat or Prevent Neurodegeneration | St. Jude Children's Research Hospital | O'NEILL, MARISOL ANN | 1633 | §102§103 | Final Rejection | 9d | Pending | Feb 16, 2023 |
| 17927038 | Recombinant P5 Promoter for Use in Reducing DNA Contamination of AAV Preparations | St. Jude Children's Research Hospital | PYLA, EVELYN Y | 1633 | §102§103 | Non-Final OA | 28d | Pending | Nov 22, 2022 |
| 17923070 | Hypoimmunogenic Cells and Uses Thereof in Immune Responses | Rxcell Inc. | HUYNH, PHUONG N | 1641 | §102§103§112Other | Non-Final OA | 34d | Pending | Nov 03, 2022 |
| 17923029 | METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION | Washington University | BELYAVSKYI, MICHAIL A | 1644 | §103 | Non-Final OA | 105d overdue | Pending | Nov 03, 2022 |
| 17913535 | Hypoimmunogenic Cells and Methods and Compositions for Their Production | Rxcell Inc. | GU, QINHUA | 1633 | §103 | Final Rejection | — | Pending | Sep 22, 2022 |
| 17801907 | RECOMBINANT FIBCD1 AND USE THEROF IN THE TREATMENT OF MUSCLE ATROPHY | St. Jude Children's Research Hospital | WHITE, ASHLEY TAYLOR | 1653 | §103 | Non-Final OA | — | Pending | Aug 24, 2022 |
| 17778138 | PENTAPEPTIDE AND METHODS OF USE THEREOF | The Board Of Trustees Of The University Of Illinois | COFFA, SERGIO | 1658 | §102 | Final Rejection | 28d | Pending | May 19, 2022 |
| 17777385 | METHOD TO INCREASE ANTIBODY YIELD DURING ION EXCHANGE CHROMATOGRAPHY | Morphosys GmbH | MCCOLLUM, ANDREA K | 1674 | §102§103§112Other | Non-Final OA | 30d overdue | Pending | May 17, 2022 |
| 17774723 | Method for Preparing Heteroleptic Triarylbismuthanes and Compounds Produced by the Same | UNIVERSITY OF HAWAII | CHENG, KAREN | 1623 | §103 | Final Rejection | 43d overdue | Pending | May 05, 2022 |
| 17628353 | COMPOSITION AND METHOD FOR PROMOTING WOUND HEALING | The Board Of Trustees Of The University Of Illiois | NIEBAUER, RONALD T | 1658 | §103 | Final Rejection | — | Pending | Jan 19, 2022 |
| 17550051 | Use of FOXP3 Enhancers to Modulate Regulatory T Cells | St. Jude Children's Research Hospital | WILSON, MICHAEL C | 1638 | — | Final Rejection | 2d overdue | Pending | Dec 14, 2021 |
| 17433900 | ORALLY INGESTED COMPOSITION FOR IMPROVING SLEEP | Wellnas.Co., Ltd. | CHICKS, ASHLI ARIANA | 1626 | §103DP | Final Rejection | — | Pending | Aug 25, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial